Trial Profile
Clinical Trials Insight: 700012650
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 14 Sep 2010
Price :
$35
*
At a glance
- Drugs Galactomannan (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Registrational; Therapeutic Use
- Sponsors Galectin Therapeutics
- 01 Dec 2006 Status changed from not yet recruiting to discontinued.
- 13 Mar 2006 New trial record.